Connection
Jennifer Dotson to Young Adult
This is a "connection" page, showing publications Jennifer Dotson has written about Young Adult.
|
|
Connection Strength |
|
 |
|
 |
|
0.693 |
|
|
|
-
Michel HK, Boyle B, David J, Donegan A, Drobnic B, Kren C, Maltz RM, McKillop HN, McNicol M, Oates M, Dotson JL. The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflamm Bowel Dis. 2022 09 01; 28(9):1420-1429.
Score: 0.099
-
Pearlstein H, Bricker J, Michel HK, Afzali A, Donegan AM, Maltz RM, Boyle BM, Dotson JL. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):563-568.
Score: 0.089
-
Dotson JL, Kappelman MD, Bricker J, Andridge R, Chisolm DJ, Crandall WV. Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status. Inflamm Bowel Dis. 2019 01 01; 25(1):194-203.
Score: 0.076
-
Jain A, Bricker J, Kappelman MD, Dotson JL. Obesity Does Not Affect Early Outcomes in Children With Newly Diagnosed Crohn Disease. J Pediatr Gastroenterol Nutr. 2018 Nov; 67(5):622-625.
Score: 0.076
-
Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV. Racial disparities in readmission, complications, and procedures in children with Crohn's disease. Inflamm Bowel Dis. 2015 Apr; 21(4):801-8.
Score: 0.059
-
Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):200-4.
Score: 0.058
-
Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011 Jan; 17(1):56-61.
Score: 0.044
-
Wright JC, Ardura MI, Dotson JL, Boyle B, Maltz RM, Michel HK. Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area. J Pediatr Gastroenterol Nutr. 2024 Dec; 79(6):1153-1163.
Score: 0.028
-
McNicol M, Abdel-Rasoul M, McClinchie MG, Morris GA, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical outcomes and cost savings of a nonmedical switch to a biosimilar in children/young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 03; 78(3):644-652.
Score: 0.027
-
Yossef L, Wright M, Benedict J, Morris GA, McNicol M, Boyle B, Dotson JL, Michel HK, Maltz RM. Patient and Caregivers' Perspectives on Biosimilar Use in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):59-63.
Score: 0.024
-
Gray A, Boyle B, Michel HK, Wright M, Dotson JL, Maltz RM. Risk of Post-Resection Recurrence in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr. 2022 06 01; 74(6):794-800.
Score: 0.024
-
Jacobson-Kelly AE, Stanek JR, Powers JM, Dotson JL, O'Brien SH. Trends in Anemia, Iron, Therapy, and Transfusion in Hospitalized Pediatric Patients with Inflammatory Bowel Disease. J Pediatr. 2020 07; 222:141-145.e1.
Score: 0.021
-
Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 09; 67(3):341-345.
Score: 0.019
-
Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):909-914.
Score: 0.018
-
Pusateri AJ, Kim SC, Dotson JL, Balint JP, Potter CJ, Boyle BM, Crandall WV. Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):592-7.
Score: 0.015
-
Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA. Histoplasmosis complicating tumor necrosis factor-a blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 01; 61(3):409-17.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|